Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07167472

Effects of Heel Height on Gait Parameters

Investigation of the Effects of Shoe Heel Heights on Gait Parameters in Healthy Individuals

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Hacettepe University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This observational study aims to investigate the effects of different shoe heel heights on gait parameters and pelvic kinematics in healthy adults aged 18-35 years. Each participant will be assessed under three conditions: barefoot, wearing shoes with 2 cm heels, and wearing shoes with 6 cm heels. Spatiotemporal gait parameters (gait speed, cadence, step length, stance and swing phase percentages, gait cycle duration) and pelvic kinematics (tilt, obliquity, rotation symmetry) will be measured using the BTS-G wireless sensor system. The study seeks to identify biomechanical differences associated with heel height and to provide data that may contribute to shoe design and individualized rehabilitation strategies.

Detailed description

This prospective observational crossover study will be conducted at Yuksek Ihtisas University. Healthy volunteers aged 18-35 years with normal body mass index and no musculoskeletal or neurological conditions affecting gait will be recruited. Participants will be excluded if they use orthotics, have had lower extremity injuries or surgery in the past 6 months, or have chronic ankle instability. Each participant will undergo gait assessments under three randomized shoe conditions: barefoot, wearing shoes with 2 cm heels, and wearing shoes with 6 cm heels. A BTS-G (BTS Bioengineering, Italy) wireless inertial sensor will be placed at the L4-L5 level to record spatiotemporal gait parameters and pelvic kinematics in the anteroposterior, mediolateral, and vertical axes during a 10-meter walk at a self-selected speed. The primary variables will include gait speed, cadence, stride length, stance and swing phase percentages, and gait cycle duration. Pelvic tilt, obliquity, and rotation symmetry indices will also be evaluated

Conditions

Timeline

Start date
2025-07-01
Primary completion
2026-01-30
Completion
2026-05-01
First posted
2025-09-11
Last updated
2026-01-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07167472. Inclusion in this directory is not an endorsement.